Leading the way to a better tomorrow
Osiris Therapeutics, Inc. is a company founded to commercialize stem cell products from adult bone marrow. These stem cells have demonstrated the ability to repair different types of tissues.
The next revolution in medical care
Osiris Therapeutics is commercializing products from a readily available and non-controversial source adult bone marrow. These stem cells have demonstrated the ability to repair different types of tissue and offer a very real opportunity to develop revolutionary new treatments for certain disease processes including autoimmune disorders, heart attacks and arthritis.
Osiris technology is based on the pioneering work of Dr. Arnold Caplan and his colleagues at Case Western Reserve University. They showed that Mesenchymal Stem Cells (MSCs) can engraft and selectively differentiate, based on the tissue environment, to such lineages as muscle, bone, cartilage, marrow stroma, tendon and fat. Due to their cellular origin and phenotype, these cells do not provoke an immune response, allowing for the development of products derived from unrelated human donors.
Osiris Therapeutics, Inc. has a number of openings which offer an exciting opportunity to participate in the development of novel therapeutic products for the regeneration of tissue using proprietary Mesenchymal Stem Cell (MSC) technology.
C. Randal Mills, Ph.D., President and Chief Executive Officer
E-mail: osiris@Osiris.com
